Cargando…

Heart Failure with Preserved Ejection Fraction—a Concise Review

PURPOSE OF REVIEW: Heart failure with preserved ejection fraction (HFpEF) is a relatively new disease entity used in medical terminology; however, both the number of patients and its clinical significance are growing. HFpEF used to be seen as a mild condition; however, the symptoms and quality of li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamczak, Daria M., Oduah, Mary-Tiffany, Kiebalo, Thomas, Nartowicz, Sonia, Bęben, Marcin, Pochylski, Mateusz, Ciepłucha, Aleksandra, Gwizdała, Adrian, Lesiak, Maciej, Straburzyńska-Migaj, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Heart Failure (HJ Eisen, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347676/ https://www.ncbi.nlm.nih.gov/pubmed/32648130 http://dx.doi.org/10.1007/s11886-020-01349-3

Ejemplares similares

What Is the Role of the Inflammation in the Pathogenesis of Heart Failure?
por: Castillo, Elena C., et al.
Publicado: (2020)

Cardiovascular Magnetic Resonance Imaging and Heart Failure
por: Liu, Chuanfen, et al.
Publicado: (2021)

Chronic Thromboembolic Pulmonary Hypertension: the Bedside
por: Matusov, Yuri, et al.
Publicado: (2021)

Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems
por: DePace, Nicholas L., et al.
Publicado: (2022)

Autonomic Testing Optimizes Therapy for Heart Failure and Related Cardiovascular Disorders
por: DePace, Nicholas L., et al.
Publicado: (2022)

The Role of Nurse Practitioners in the Management of Heart Failure Patients and Programs
por: King-Dailey, Kathaleen, et al.
Publicado: (2022)

How Does COVID-19 Affect the Heart?
por: Sewanan, Lorenzo R., et al.
Publicado: (2023)

The Role of Depression on Treatment Adherence in Patients with Heart Failure–a Systematic Review of the Literature
por: Poletti, Valentina, et al.
Publicado: (2022)

Contemporary Data on the Status and Medical Management of Acute Heart Failure
por: Bazmpani, Maria Anna, et al.
Publicado: (2022)

Donation After Circulatory Death: A New Frontier
por: Joshi, Yashutosh, et al.
Publicado: (2022)

Accurate Classification of Non-ischemic Cardiomyopathy
por: Wang, Yifan, et al.
Publicado: (2023)

The Effect of EECP on Ischemic Heart Failure: a Systematic Review
por: Xu, Ling, et al.
Publicado: (2023)

Efficacy of Ranolazine to Improve Diastolic Performance in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-analysis
por: Putri, Desak Ketut Sekar Cempaka, et al.
Publicado: (2023)

Right Heart Phenotype in Heart Failure With Preserved Ejection Fraction
por: Guazzi, Marco, et al.
Publicado: (2021)

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis
por: Beale, Anna L, et al.
Publicado: (2019)

Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction
por: Salah, Khibar, et al.
Publicado: (2019)

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
por: Son, Mi Kyoung, et al.
Publicado: (2020)

Diastolic index as a short-term prognostic factor in heart failure with preserved ejection fraction
por: Hoshida, Shiro, et al.
Publicado: (2020)

Colchicine in patients with heart failure and preserved left ventricular ejection fraction: rationale and design of a prospective, randomised, open-label, crossover clinical trial
por: Shchendrygina, Anastasia, et al.
Publicado: (2023)

Reporting trends of randomised controlled trials in heart failure with preserved ejection fraction: a systematic review
por: Zheng, Sean L, et al.
Publicado: (2016)

Mild aortic valve disease and the diastolic pressure–volume relationship in heart failure with preserved ejection fraction
por: Verbrugge, Frederik H, et al.
Publicado: (2021)

Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study
por: Hage, Camilla, et al.
Publicado: (2015)

Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis
por: Zheng, Sean Lee, et al.
Publicado: (2018)

Baseline characteristics of patients with heart failure and preserved ejection fraction at admission with acute heart failure in Saudi Arabia
por: Abohammar, Samah, et al.
Publicado: (2017)

Development of algorithms for determining heart failure with reduced and preserved ejection fraction using nationwide electronic healthcare records in the UK
por: Sundaram, Varun, et al.
Publicado: (2022)

Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model
por: Sotomi, Yohei, et al.
Publicado: (2023)

Does lateral approach preserve the right ventricular function after HeartMate 3 insertion?
por: Hayashi, Hideyuki, et al.
Publicado: (2023)

Developing a contemporary community clinic for patients with heart failure with preserved ejection fraction within the current National Health Service model
por: Tran, Patrick, et al.
Publicado: (2022)

Non-invasive intraventricular pressure differences estimated with cardiac MRI in subjects without heart failure and with heart failure with reduced and preserved ejection fraction
por: Londono-Hoyos, Francisco, et al.
Publicado: (2019)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: Abboud, Andrew, et al.
Publicado: (2021)

Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis
por: Basile, Christian, et al.
Publicado: (2023)

Ischaemia change with revascularisation versus medical therapy in reduced ejection fraction
por: Mentz, Robert J, et al.
Publicado: (2015)

Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure
por: Gijsberts, Crystel M, et al.
Publicado: (2016)

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
por: Margonato, Davide, et al.
Publicado: (2020)

Association of early versus delayed normalisation of left ventricular ejection fraction with mortality in ischemic cardiomyopathy
por: Schiffer, Walter B, et al.
Publicado: (2021)

New Insights in (Inter)Cellular Mechanisms by Heart Failure with Preserved Ejection Fraction
por: Tschöpe, Carsten, et al.
Publicado: (2014)

Implantation of a vagus nerve stimulator for patients with heart failure with reduced ejection fraction: An educational video
por: Al Rameni, Dina, et al.
Publicado: (2022)

Characteristics and clinical outcomes of patients with acute heart failure with a supranormal left ventricular ejection fraction
por: van Essen, Bart J., et al.
Publicado: (2022)

Incremental value of mineralocorticoid receptor antagonists in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
por: Benini, Annachiara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9luaab6ea67mdq1p334oq37hh3